Madrigal pharmaceuticals to release first-quarter 2025 financial results and host webcast on may 1, 2025

Conshohocken, pa., april 18, 2025 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq: mdgl), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (mash), announced today that it will release its first-quarter 2025 financial results on thursday, may 1, 2025, prior to the open of the u.s. financial markets.
MDGL Ratings Summary
MDGL Quant Ranking